Table 2:
Outcomes of SARS-CoV-2 positive versus negative patients with AIS undergoing EVTa
| Outcome | Univariate ORs | Multivariate | Multivariate |
|---|---|---|---|
| SARS-CoV-2 positive versus negative EVT patients | (95% CI) | Model 1 ORs (95% CI) | Model 2 ORs (95% CI) |
| Favorable discharge location (home/rehabilitation vs other) | 0.82 (0.616, 1.091), P = .1733 | 0.66 (0.48, 0.90), P = .0092 | 0.67 (0.49, 0.93), P = .0146 |
| Good mRS at discharge (0–2) | 0.608 (0.054, 6.779), P = .6857 | 0.17 (0.04, 0.62), P = .0075 | 0.15 (0.04, 0.60), P = .0071 |
| sICH | 0.956 (0.493,1.854), P = .8951 | 1.00 (0.52, 1.94), P = .9904 | 0.97 (0.50, 1.88), P = .9321 |
| In-hospital mortality | 0.1735 (0.474, 1.128), P = .1569 | 1.58 (1.02, 2.45), P = .0408 | 1.65 (1.06, 2.58), P = .0274 |
| Independent ambulation at discharge (restricted to patients who were independently ambulating at presentation) | 0.989 (0.664,1.472), P = .9562 | 0.92 (0.61, 1.39), P = .6899 | 0.95 (0.62, 1.45), P = .8097 |
a
Multivariate model 1 adjusts for age, sex, race, insurance, diabetes, atrial fibrillation, arrival mode, IV thrombolysis, and period. Multivariate model 2 adjusts for all variables in Supplemental Data.